继发性甲状旁腺功能亢进的分子发病机制及治疗进展(4)
[18]Hutchisen A.The novel non-aluminum,non-calcium phosphate binder,Fosrenol,is an efective treatment for hyperphesphatemia and has a good safety profile.J Am See Nephrol,2002,13:385A
[19]Slatopolsky E.New analogs of vitamin D3.Kidney Int,1999,56:S46-S51
[20]Hirata M et al. (2002) A comparison between1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone and calcemic action. Nephrol Dial Transplant 17 (Suppl 10): 41-45
[21]Akizawa T et al. Long-term effect of 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in haemodialysis patients. One year administration study. Nephrol Dial Transplant(2002) 17 (Suppl 10): 28-36
[22]Sprague SM et al. (2003) Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.Kidney Int 63: 1483-1490
[23]Teng M et al. (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.N Engl J Med 349: 446-456
[24]Hansen JT,Brown EM. THE Calcium- sensing receptor in normal physiology and pathophysiology: A review. Crit rev in clin lab sciences, 2005, 42(1): 35-70
[25]Cunningham J,et.al,Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.Kidney Int 2005 Oct;68(4):1793-800
[26]K Shiizaki,Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells。Kidney Int 2006; (suppl 70)s12-15, http://www.100md.com(刘洁琼)
[19]Slatopolsky E.New analogs of vitamin D3.Kidney Int,1999,56:S46-S51
[20]Hirata M et al. (2002) A comparison between1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone and calcemic action. Nephrol Dial Transplant 17 (Suppl 10): 41-45
[21]Akizawa T et al. Long-term effect of 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in haemodialysis patients. One year administration study. Nephrol Dial Transplant(2002) 17 (Suppl 10): 28-36
[22]Sprague SM et al. (2003) Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.Kidney Int 63: 1483-1490
[23]Teng M et al. (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.N Engl J Med 349: 446-456
[24]Hansen JT,Brown EM. THE Calcium- sensing receptor in normal physiology and pathophysiology: A review. Crit rev in clin lab sciences, 2005, 42(1): 35-70
[25]Cunningham J,et.al,Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism.Kidney Int 2005 Oct;68(4):1793-800
[26]K Shiizaki,Direct injection of calcitriol or its analog into hyperplastic parathyroid glands induces apoptosis of parathyroid cells。Kidney Int 2006; (suppl 70)s12-15, http://www.100md.com(刘洁琼)